Shares of Evoke plc (LON:EVOK – Get Free Report) dropped 10% on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares changed hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on EVOK shares. Jefferies Financial Group reiterated a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank cut their target price on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th.
Check Out Our Latest Stock Analysis on Evoke
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, research analysts anticipate that Evoke plc will post 12.7648305 EPS for the current year.
Insider Buying and Selling at Evoke
In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by corporate insiders.
About Evoke
Recommended Stories
- Five stocks we like better than Evoke
- How to Invest in Small Cap Stocks
- MarketBeat Week in Review – 03/24 – 03/28
- Do ETFs Pay Dividends? What You Need to Know
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What to Know About Investing in Penny Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.